Mostra i principali dati dell'item

dc.contributor.authorMuñoz Moreno, Diego
dc.contributor.authorPérez López, Gilberto
dc.contributor.authorÁlvarez-Sala Walther, Luis Antonio
dc.contributor.authorRueda Camino, José Antonio
dc.contributor.authorMartín Vallejo, Francisco Javier 
dc.contributor.authorGonzález Albarrán, Olga
dc.date.accessioned2025-12-15T09:43:22Z
dc.date.available2025-12-15T09:43:22Z
dc.date.issued2025
dc.identifier.citationMuñoz Moreno D, Pérez López G, Álvarez-Sala Walther LA, Rueda Camino JA, Martín Vallejo J, González Albarrán O. Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting. Clinical Medicine Insights: Endocrinology and Diabetes. 2025;18. doi:10.1177/11795514251323831es_ES
dc.identifier.issn1179-5514
dc.identifier.urihttp://hdl.handle.net/10366/168285
dc.description.abstract[EN]New-onset type 2 diabetes mellitus (T2DM) is a common clinical scenario in the hospital settings. However, data on the baseline characteristics of these patients at diagnosis in Spain remain limited. This study aims to describe the characteristics of 165 patients admitted to a Spanish tertiary hospital with new-onset T2DM. We analysed the use of different treatment regimens at discharge and metabolic control during follow-up. A retrospective, single-centre cohort study was conducted at General University Gregorio Marañón Hospital, between January 2018 and April 2021. A total of 165 patients participated, with a mean age of 56.4 years, 62.4% of whom were men. Diabetes-related complications were observed in 24.8% of patients at diagnosis. Combined antidiabetic treatment was required in 87% of cases. The mean baseline HbA1c was 10.8%, which decreased by 4.9% after 8 months of follow-up. The clinical heterogeneity and severity of hyperglycaemia in this cohort presented management challenges, in contrast to outpatient settings. Monotherapy was rarely used, with higher adoption of SGLT-2 inhibitors and GLP-1 receptor agonists compared to other studies. Additional research is needed to refine treatment strategies and optimize care for patients with newly diagnosed T2DM.es_ES
dc.language.isoenges_ES
dc.publisherSAGE Publicationses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectType 2 diabetes mellituses_ES
dc.subjectCombination therapyes_ES
dc.subjectHospitalizationes_ES
dc.subjectMetabolic controles_ES
dc.subjectNew-onsetes_ES
dc.titleClinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1177/11795514251323831es_ES
dc.identifier.doi10.1177/11795514251323831
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid40078450
dc.identifier.essn1179-5514
dc.journal.titleClinical Medicine Insights: Endocrinology and Diabeteses_ES
dc.volume.number18es_ES
dc.page.initial11795514251323831es_ES
dc.type.hasVersioninfo:eu-repo/semantics/draftes_ES


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional